Literature DB >> 11679517

Testicular sperm extraction in a patient with metachronous bilateral testicular cancer.

F M Köhn1, I Schroeder-Printzen, W Weidner, M Montag, H van der Ven, W B Schill.   

Abstract

A new indication for testicular tissue cryopreservation is demonstrated in a patient with metachronous bilateral testicular tumours and azoospermia. At the age of 18 (1982) the patient underwent left orchidectomy and radical retroperitoneal lymphadenectomy for a testicular teratoma (pT1N0M0). Semen samples were not cryopreserved because of absence of motile spermatozoa after thawing. Seventeen years after the primary testicular cancer, a seminoma of the contralateral right testis was diagnosed (pT1N0M0). Since the patient was azoospermic, no semen samples could be cryopreserved. However, spermatozoa were detected in testicular biopsy material of the right testis and were cryopreserved for ICSI. Since all spermatozoa were dead after thawing, testicular sperm extraction (TESE) was performed in the remaining tissue samples at the time of ICSI treatment. Only spermatids could be extracted from frozen-thawed samples due to the inhomogeneous distribution of spermatogenic activity in the testicular tissue. Although one oocyte was fertilized with these spermatids, a clinical pregnancy was not achieved. Despite the disappointing results of ICSI in the couple presented here, this case report demonstrates that cryopreservation of testicular tissue and TESE should be considered in patients with bilateral testicular tumours and azoospermia, if frozen semen samples are not available.

Entities:  

Mesh:

Year:  2001        PMID: 11679517     DOI: 10.1093/humrep/16.11.2343

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  3 in total

1.  Successful pregnancy outcome using sperm from severely diseased men with testicular cancer and collagen disease: Three case reports.

Authors:  Sachiko Sasaki; Keiko Sasaki; Sayaka Takahashi; Toshie Sasaki; Koichi Kyono; Yasuhisa Araki
Journal:  Reprod Med Biol       Date:  2004-05-20

2.  A male phenotype (XY) hermaphrodite treated for seminoma, fathered a healthy child by IVF-ICSI technique.

Authors:  Faheem Zayed; Ibrahim Ghalayini; Ismail Matalka
Journal:  J Assist Reprod Genet       Date:  2008-07-22       Impact factor: 3.412

3.  Azoospermia and the cancer patient: are there any options?

Authors:  Jason R Kovac; Larry I Lipshultz
Journal:  Asian J Androl       Date:  2016 May-Jun       Impact factor: 3.285

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.